bc3402
Showing 1 - 1 of 1
MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
- BC3402
- Azacitidine
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023